Acquisition of BioCell Lugano, Switzerland

FamiCord Group acquired BioCell Lugano, which includes a modern laboratory in Switzerland. This is another important step towards expanding the scope of activities in western Europe, further enhancing FamiCord’s ability to offer innovative stem cell banking and regenerative medicine solutions across the continent.

The laboratory developed and started to commercialize technology of banking perinatal tissues such as placental villi and amniotic fluid cells. FamiCord plans to further expand BioCell Lugano laboratory capabilities, which currently serves B2B clients in Italy and Egypt. Company plans to expand this activity to offer cord blood banking which currently is not in the scope of BioCell services.

Recently added

17 November 2025 FamiCord Group Recognized as Europe’s Leading Stem Cell Bank FamiCord is the largest stem cell bank in Europe and the third largest in the world. The quality of its services is validated by international certifications, and the company has now been recognized as Europe’s Leading Stem Cell Bank by Life Sciences Review, highlighting its commitment to excellence, clinical reliability, and innovation in stem cell banking.FamiCord Group have been awarded as “The Europe’s Leading Stem Cell Bank” , independent experts jury underlined FamiCord has established itself as a leading provider in the field, guiding families through the collection, processing, and long-term preservation of cord blood and perinatal tissues. Read more
27 August 2025 Infantile cerebral palsy – Convincing evidence for the use of perinatal stem cells Leipzig, July 15, 2025 - Cerebral palsy (CP) continues to be one of the most common motor disabilities in childhood and is associated with permanent movement restrictions and spasticity. The therapeutic potential of stem cells from umbilical cord blood and tissue was discussed at the 37th Annual Meeting of the European Academy Of Childhood-onset Disabilities (EACD) and the 4th Meeting of the International Alliance of Academies of C hildhood Disability (IAACD) from June 24 - 28, 2025 in Heidelberg. As part of a symposium supported by FamiCord AG, international experts presented the current state of research and reported on the results from clinical practice. Read more